Acadia Healthcare (NASDAQ:ACHC) Price Target Cut to $65.00 by Analysts at KeyCorp

Acadia Healthcare (NASDAQ:ACHC) had its target price reduced by KeyCorp from $70.00 to $65.00 in a report published on Monday morning,Benzinga reports. They currently have an overweight rating on the stock.

Several other research firms have also weighed in on ACHC. Barclays lowered shares of Acadia Healthcare from an “overweight” rating to an “equal weight” rating and lowered their price objective for the stock from $43.00 to $35.00 in a research note on Friday. Royal Bank of Canada restated an “outperform” rating and issued a $64.00 price objective on shares of Acadia Healthcare in a research note on Friday, January 10th. Cantor Fitzgerald reiterated a “neutral” rating and set a $52.00 target price on shares of Acadia Healthcare in a research note on Tuesday, December 10th. StockNews.com cut Acadia Healthcare from a “hold” rating to a “sell” rating in a research note on Monday, January 6th. Finally, TD Cowen reduced their price objective on shares of Acadia Healthcare from $70.00 to $66.00 and set a “buy” rating for the company in a research report on Tuesday, January 7th. One research analyst has rated the stock with a sell rating, three have issued a hold rating and five have issued a buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and an average price target of $56.31.

Acadia Healthcare Price Performance

Shares of NASDAQ ACHC opened at $29.26 on Monday. Acadia Healthcare has a fifty-two week low of $29.19 and a fifty-two week high of $86.56. The stock has a market capitalization of $2.72 billion, a price-to-earnings ratio of 9.59, a PEG ratio of 1.46 and a beta of 1.30. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.07 and a quick ratio of 1.07. The business has a 50-day moving average of $41.93 and a 200-day moving average of $51.32.

Institutional Inflows and Outflows

Several large investors have recently added to or reduced their stakes in ACHC. DekaBank Deutsche Girozentrale acquired a new position in shares of Acadia Healthcare in the third quarter valued at about $86,000. State of Alaska Department of Revenue increased its holdings in shares of Acadia Healthcare by 7.3% during the third quarter. State of Alaska Department of Revenue now owns 10,735 shares of the company’s stock worth $680,000 after purchasing an additional 730 shares during the period. Harbor Capital Advisors Inc. raised its position in shares of Acadia Healthcare by 90.7% in the third quarter. Harbor Capital Advisors Inc. now owns 22,582 shares of the company’s stock valued at $1,432,000 after buying an additional 10,740 shares in the last quarter. Principal Financial Group Inc. boosted its stake in shares of Acadia Healthcare by 2.1% in the third quarter. Principal Financial Group Inc. now owns 656,889 shares of the company’s stock valued at $41,653,000 after buying an additional 13,368 shares during the period. Finally, Verdence Capital Advisors LLC grew its position in Acadia Healthcare by 32.8% during the third quarter. Verdence Capital Advisors LLC now owns 4,664 shares of the company’s stock worth $296,000 after buying an additional 1,152 shares in the last quarter.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.